PLUR

Pluri Inc. - Common Stock (PLUR)

About Pluri Inc. - Common Stock (PLUR)

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

Details

Daily high

$5.17

Daily low

$4.53

Price at open

$4.75

52 Week High

$7.13

52 Week Low

$3.33

Market cap

32.5M

Dividend yield

0.00%

Volume

10,073

Avg. volume

34,257

P/E ratio

-1.26

Pluri Inc. - Common Stock News